Legend Biotech (LEGN) Change in Working Capital (2025 - 2026)
Legend Biotech's (LEGN) quarterly Change in Working Capital came in at $2.8 million in Q1 2026, up 154.55% YoY from $1.1 million in Q1 2025, and up 154.55% on a QoQ basis from $1.1 million in Q1 2025.
Legend Biotech (LEGN) Change in Working Capital (2025 - 2026) Analysis & Trends
Legend Biotech (LEGN) has 2 years of Change in Working Capital data on file, last reported at $2.8 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn | -400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -400,000.00 |
| Jun 30, 2026 | -400,000.00 |
| Mar 31, 2026 | 2.80 Mn |
| Mar 31, 2026 | 2.80 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |